Cover Feature: Aptamers for SARS-CoV-2: Isolation, Characterization, and Diagnostic and Therapeutic Developments (Anal. Sens. 5/2022).
Anal Sens
; 2(5): e202200035, 2022 Sep.
Article
in English
| MEDLINE | ID: covidwho-2034714
ABSTRACT
The cover feature image shows nucleic acid aptamers armed and ready for our battle against the monstrous SARS-CoV-2 virus. Often thought of as "chemical antibodies", these molecular recognition elements are equipped with several unique benefits and have thus been a popular research subject worldwide. Many aptamers for recognizing the spike and nucleocapsid proteins of SARS-CoV-2 have been developed and examined as diagnostic and therapeutic weaponry for the war against COVID-19 and future pandemics. More information can be found in the Review by J.â
D. Brennan, Y. Li, and co-workers.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Anal Sens
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS